CT News and Research

RSS

Researchers solve the mystery of silent hypoxia caused by COVID-19

More than six months since COVID-19 began spreading in the United States, scientists are still solving the many puzzling aspects of how the novel coronavirus attacks the lungs and other parts of the body.

19 Nov 2020

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).

19 Nov 2020

NIH-funded study to test emergency treatment for devastating stroke in Memphis

The University of Tennessee Health Science Center's Stroke Team is joining researchers from more than 100 hospitals worldwide to conduct a National Institutes of Health (NIH)-funded research study called FASTEST that will test the safety and efficacy of a medication called recombinant factor Vlla to prevent hemorrhage expansion in patients with strokes caused by bleeding in the brain - intracerebral hemorrhage strokes.

19 Nov 2020

RUDN University dentists identify reason for early deterioration of dental implants

A team of dentists from RUDN University confirmed that a change in the dominant side of chewing is a reason for the early deterioration of dental implants.

19 Nov 2020

TB researchers uncover crucial clue that explains antibiotic resistance in bacteria

For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.

18 Nov 2020

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a study being presented at the annual meeting of the Radiological Society of North America.

18 Nov 2020

Revolutionary 3D color wrist scanner to be tested in international trial

A revolutionary compact 3D colour wrist scanner invented by a University of Otago, Christchurch professor will soon be tested in a large scale international clinical trial. This development follows a promising pilot study with New Zealand orthopaedic patients.

16 Nov 2020

Corticosteroids can help in survival of elderly patients with severe COVID-19

A new study group based in France have looked at the rates of survival among elderly patients with COVID-19 who were administered with corticosteroids.

16 Nov 2020

Care pathways for pregnant women with COVID‐19

A recent review published in the journal Global Challenges in October 2020, sums up what is currently known about the treatment of COVID-19 during pregnancy and offers recommendations for how healthcare professions might better manage pregnant COVID-19 patients in the future.

16 Nov 2020

Study: 68% of people believe they should ‘reach out’ to carers during coronavirus second wave

Amidst a coronavirus second wave, a study has found that 68% of people believe they should ‘reach out’ to carers more often – with 60% of respondents only asking carers how they are ‘now and again’, ‘rarely’ or ‘almost never’; leaving carers at risk of feeling forgotten.

16 Nov 2020

New screening strategy can help identify individuals with higher probability of developing heart disease

More than 40% of middle-aged adults have silent coronary artery disease. Researchers have developed a new screening questionnaire to help identify individuals at the highest risk for coronary artery disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

New methodology predicts mutation hotspots in SARS-CoV-2 virus

Researchers in Sweden and China have presented a new methodology for predicting mutation “hotspot” sites within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

15 Nov 2020

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking research presented today in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

Taking omega-3 fatty acids and vitamin D3 supplements does not neither increase nor decrease the risk of developing atrial fibrillation, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Using artificial intelligence imaging analysis methods for COVID-19 clinical diagnosis

Announcing a new article publication for BIO Integration journal. In this review article the authors Yun Chen, Gongfa Jiang, Yue Li, Yutao Tang, Yanfang Xu, Siqi Ding, Yanqi Xin and Yao Lu from Xiangtan University, Xiangtan, China and Sun Yat-sen University, Guangzhou, China consider the application of artificial intelligence imaging analysis methods for COVID-19 clinical diagnosis.

11 Nov 2020

Endothelial cells resistant to SARS-CoV-2 infection

A team of scientists from Imperial College London has conducted a series of in vitro studies to investigate the susceptibility of endothelial cells to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the causative pathogen of coronavirus disease 2019 (COVID-19).

10 Nov 2020

Open-source online platform offers better insight into biomedical images

Recent years have seen dramatic improvements in imaging technologies that result in higher resolutions and faster acquisition times.

10 Nov 2020

New evidence of neurobiological mechanism for hallucinations and delusions found

A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found evidence of a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation.

9 Nov 2020

‘A great day for science and humanity’; Pfizer’s COVID-19 vaccine is found to be 90% effective

Pfizer and BioNTech have today announced their new vaccine candidate (BNT162b2) is 90% effective against SARS-CoV-2.

9 Nov 2020

CT News and Research

Researchers solve the mystery of silent hypoxia caused by COVID-19

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

NIH-funded study to test emergency treatment for devastating stroke in Memphis

RUDN University dentists identify reason for early deterioration of dental implants

TB researchers uncover crucial clue that explains antibiotic resistance in bacteria

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Revolutionary 3D color wrist scanner to be tested in international trial

Corticosteroids can help in survival of elderly patients with severe COVID-19

Care pathways for pregnant women with COVID‐19

Study: 68% of people believe they should ‘reach out’ to carers during coronavirus second wave

New screening strategy can help identify individuals with higher probability of developing heart disease

New methodology predicts mutation hotspots in SARS-CoV-2 virus

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Using artificial intelligence imaging analysis methods for COVID-19 clinical diagnosis

Endothelial cells resistant to SARS-CoV-2 infection

Open-source online platform offers better insight into biomedical images

New evidence of neurobiological mechanism for hallucinations and delusions found

‘A great day for science and humanity’; Pfizer’s COVID-19 vaccine is found to be 90% effective

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News